170
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Salivary Amylase Gene Copy Number Is Associated with the Obesity and Inflammatory Markers in Children

, , &
Pages 1695-1701 | Published online: 19 May 2020

References

  • Barnes AS. The epidemic of obesity and diabetes: trends and treatments. Tex Heart Inst J. 2011;38:142–144.
  • Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977. doi:10.1161/01.CIR.67.5.968
  • WHO. Obesity and overweight fact sheet. Geneva, Switzerland: World Health Organization; 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed December 9, 2019.
  • Shorter E. Current research into the association between DNA copy number variation (CNV) and obesity. Biosci Horiz. 2017;10.
  • Viljakainen H, Andersson-Assarsson JC, Armenio M, et al. Low copy number of the AMY1 locus Is associated with early-onset female obesity in Finland. PLoS One. 2015;10:e0131883. doi:10.1371/journal.pone.0131883
  • Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6:221–234. doi:10.1038/nrg1556
  • Moleres A, Martinez JA, Marti A. Genetics of obesity. Curr Obes Rep. 2013;2:23–31. doi:10.1007/s13679-012-0036-5
  • Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61:437–455. doi:10.1146/annurev-med-100708-204735
  • Beckmann JS, Estivill X, Antonarakis SE. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet. 2007;8:639–646. doi:10.1038/nrg2149
  • Girirajan S, Campbell CD, Eichler EE. Human copy number variation and complex genetic disease. Annu Rev Genet. 2011;45:203–226. doi:10.1146/annurev-genet-102209-163544
  • Leon-Mimila P, Villamil-Ramirez H, Lopez-Contreras BE, et al. Low salivary amylase gene (AMY1) copy number is associated with obesity and gut Prevotella abundance in Mexican children and adults. Nutrients. 2018;10(11):1607. doi:10.3390/nu10111607
  • Marcovecchio ML, Florio R, Verginelli F, et al. Low AMY1 gene copy number is associated with increased body mass index in prepubertal boys. PLoS One. 2016;11:e0154961. doi:10.1371/journal.pone.0154961
  • Venkatapoorna CMK, Ayine P, Parra EP, et al. Association of salivary amylase (AMY1) gene copy number with obesity in Alabama elementary school children. Nutrients. 2019;11:1379. doi:10.3390/nu11061379
  • Falchi M, El-Sayed Moustafa JS, Takousis P, et al. Low copy number of the salivary amylase gene predisposes to obesity. Nat Genet. 2014;46(5):492–497. doi:10.1038/ng.2939
  • Rukh G, Ericson U, Andersson-Assarsson J, et al. Dietary starch intake modifies the relation between copy number variation in the salivary amylase gene and BMI. Am J Clin Nutr. 2017;106:256–262. doi:10.3945/ajcn.116.149831
  • Yong RY, Mustaffa SB, Wasan PS, et al. Complex copy number variation of AMY1 does not associate with obesity in two East Asian cohorts. Hum Mutat. 2016;37:669–678. doi:10.1002/humu.22996
  • Selvaraju V, Babu JR, Geetha T. Association of salivary C-reactive protein with the obesity measures and markers in children. Diabetes Metab Syndr Obes. 2019;12:1239–1247. doi:10.2147/DMSO.S211624
  • Marquina C, Mousa A, Belski R, et al. Increased inflammation and cardiometabolic risk in individuals with low AMY1 copy numbers. J Clin Med. 2019;8(3):382. doi:10.3390/jcm8030382
  • de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660–667. doi:10.2471/BLT.07.043497
  • Sharma AK, Metzger DL, Daymont C, et al. LMS tables for waist-circumference and waist-height ratio Z-scores in children aged 5–19 y in NHANES III: association with cardio-metabolic risks. Pediatr Res. 2015;78:723–729. doi:10.1038/pr.2015.160
  • Mejia-Benitez MA, Bonnefond A, Yengo L, et al. Beneficial effect of a high number of copies of salivary amylase AMY1 gene on obesity risk in Mexican children. Diabetologia. 2015;58:290–294. doi:10.1007/s00125-014-3441-3
  • Fortmann Stephen P, Ford E, Criqui Michael H, et al. CDC/AHA Workshop on markers of inflammation and cardiovascular disease: application to Clinical and Public Health Practice: report from the population science discussion group. Circulation. 2004;110:e554–e559. doi:10.1161/01.CIR.0000148982.95775.BF
  • Hubacek JA, Peasey A, Pikhart H, et al. APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Hum Immunol. 2010;71:304–308. doi:10.1016/j.humimm.2010.01.008
  • Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm. 2008;2008:109502. doi:10.1155/2008/109502
  • Burnett MS, Devaney JM, Adenika RJ, et al. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab. 2006;91:64–68. doi:10.1210/jc.2005-1653
  • Chen BH, Song Y, Ding EL, et al. Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care. 2009;32:329–334. doi:10.2337/dc08-1625
  • Heidemann C, Sun Q, van Dam RM, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149:307–316. doi:10.7326/0003-4819-149-5-200809020-00005
  • Liu GL, Fu XH, Jiang LH, et al. Serum resistin concentration and insulin resistance in obese children. Zhonghua Er Ke Za Zhi. 2006;44:114–117.
  • Norata GD, Ongari M, Garlaschelli K, et al. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol. 2007;156:279–284. doi:10.1530/eje.1.02338
  • Osawa H, Ochi M, Tabara Y, et al. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes. Clin Endocrinol (Oxf). 2008;69:74–80. doi:10.1111/j.1365-2265.2007.03154.x
  • Singh AK, Tiwari S, Gupta A, et al. Association of resistin with metabolic syndrome in Indian subjects. Metab Syndr Relat Disord. 2012;10:286–291. doi:10.1089/met.2011.0128
  • Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond). 2005;29:146–150. doi:10.1038/sj.ijo.0802839
  • Fu CP, Sheu WH, Lee IT, et al. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome. Clin Chem Lab Med. 2015;53:623–629. doi:10.1515/cclm-2014-0468
  • Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2003;100:7265–7270. doi:10.1073/pnas.1133870100
  • Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220:T47–T59. doi:10.1530/JOE-13-0339
  • Choi YJ, Nam YS, Yun JM, et al. Association between salivary amylase (AMY1) gene copy numbers and insulin resistance in asymptomatic Korean men. Diabet Med. 2015;32:1588–1595. doi:10.1111/dme.12808
  • Arredouani A, Stocchero M, Culeddu N, et al. Metabolomic profile of low-copy number carriers at the salivary alpha-amylase gene suggests a metabolic shift toward lipid-based energy production. Diabetes. 2016;65:3362–3368. doi:10.2337/db16-0315